Abbott, Mead Johnson and Reckitt
Jury asked to award more than $6 billion in preterm formula case against Abbott, Reckitt's Mead
A lawyer for a Missouri mother on Wednesday asked a jury to make Abbott and Reckitt's Mead Johnson pay a total of more than $6 billion in the latest trial over claims that the companies' formulas for premature babies caused a severe intestinal illness.
By Brendan Pierson (Reuters) -Abbott and Reckitt unit Mead Johnson are not responsible for a young boy's debilitating ...
Marie Thibault, an analyst from BTIG, reiterated the Buy rating on Abbott Laboratories (ABT – Research Report). The associated price ...
A St. Louis jury handed Abbott Laboratories a win Thursday, deciding that Abbott, another company and a hospital were not ...
The ruling by a Missouri state court jury is a rare legal win for Abbott Laboratories, maker of Similac formula, and Reckitt, ...
The infant formula manufacturers were facing $6.2bn in punitive damages over allegations their infant formula products caused ...
The lawsuit alleged that Mead Johnson, which makes baby formula, had failed to warn that its products could cause the illness ...
Missouri Mother Pursues $6 Billion in Premature Formula Lawsuit Background: A Missouri mother, Elizabeth Whitfield, has filed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback